|
CDNA | Caredx, Inc. |
|
|
CDNA | Caredx, Inc. |
| Services-Medical Laboratories |
| Book value per $ invested | $ 0.30 |
| Leverage | 22.93% |
| Market Cap | $ 1.3B |
| PE | 24.94 |
| Dividend Yield | 0.00% |
| Profit | $ 50.9m |
| Margin | 15.31% |
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.